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Abstract
National and international governments are in the process of establishing testing programs and strategies to assess
the safety of currently used chemicals with regard to their potential to interact with the endocrine system of man
and wildlife, resulting in potential impacts on reproduction, growth, and/or development. Specifically, the USA,
Japan, EU, and OECD have established testing approaches and regulatory frameworks with aim to assess the risks
associated with chemicals that have endocrine disrupting properties (EDCs). While there has been a large amount
of efforts over the past two decades in context with the assessment of chemical safety, no comparable attempts
to harmonize and mutually accept testing strategies and decision-making criteria for environmental monitoring
and assessment exist to date for EDCs. In fact, many of the current environmental programs such as the European
Water Framework Directive (WFD) or the US Clean Water Act do not explicitly test for EDCs, and considering the
unique requirements and endpoints required to assess the endocrine potential of a sample, these programs are
unlikely to appropriately address exposure to these chemicals. This is of great concern since EDCs are ubiquitous in
the environment, especially in aquatic ecosystems. One of most important sources for EDCs in the environment is
the effluent from sewage treatment plants. Many EDCs such as the natural and synthetic estrogens 17b-estradiol
and 17a-ethinylestradiol, respectively, are not completely removed with conventional wastewater treatment
systems. In recognition of these concerns, in Europe, there is increasing pressure to further develop advanced
wastewater treatment methods, such as ozonation and activated carbon treatment for a broad application in
municipal wastewater treatment. Another issue is the continuing lack of understanding of the environmental
relevance of the phenomenon of ED. A great number of studies have been conducted to describe potential ED in
wild and laboratory animals. Most of these studies relied on biomarkers of estrogenicity such as vitellogenin
induction in males and mild histological alterations (e.g. occurrence of testicular oocytes), and to date - with few
exceptions - no convincing evidence of population relevant impacts of exposure to EDC in the wild exist. In
conclusion, while there has been a great deal of research and efforts in context with the hazard assessment and
regulation of EDCs, there is still a large number of remaining uncertainties and issues. These range from animal
rights concerns due to significant increases in the use of animals to fulfill testing requirements, associated needs
for alternative testing concepts such as in vitro, in silico, and modeling approaches, lack of understanding of the
relevance of the exposure of man and wildlife to EDCs, and the need for inclusion of EDCs in current
environmental programs such as the WFD. In this article we attempted to summarize the current state-of-the-art of
regulatory and scientific approaches in context with EDCs, and to identify issues and future needs to address
current shortcomings in the field.
* Correspondence: markus.hecker@usask.ca; henner.hollert@bio5.rwth-aachen.
de
1Toxicology Centre, University of Saskatchewan, 44 Campus Drive, Saskatoon,
SK S7N 5B3, Canada
2Department of Ecosystem Analysis, Institute for Environmental Research,
RWTH Aachen University, Worringerweg 1, 52074 Aachen, Germany
Full list of author information is available at the end of the article
Hecker and Hollert Environmental Sciences Europe 2011, 23:15
http://www.enveurope.com/content/23/1/15
© 2011 Hecker and Hollert; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Background
Since the middle of the 1990 s, there has been increas-
ing awareness and concern regarding the exposure to
chemicals that have the potential to interfere with the
endocrine system, and thus, may cause health effects in
people and wildlife. In fact, a great number of chemicals
have been identified that were found to interact with
the endocrine system of different animals in laboratory
studies, and there are increasing reports of endocrine
disruption in wild animals [1,2]. The potential role of
endocrine disrupting chemicals in the environment has
been discussed extensively for several years in both
science and the broader public. On the one hand, there
is evidence from various laboratory experiments that
estrogenic or estrogen-like compounds have the poten-
tial of affecting development of the reproductive and
nervous systems, as well as behavior and immune
response in higher organisms [3,4]. On the other hand,
it is still unclear if environmentally relevant concentra-
tions of xenoestrogens can result in deleterious effects
in wildlife populations, and to date - with few excep-
tions - there has been no direct evidence of such popu-
lation relevant impacts in the wild [5,6]. In fact, few
studies have attempted to explore the ecological rele-
vance of the exposure to endocrine active chemicals
under field conditions. One example is a recent whole-
lake study that was conducted over 10 years at the
Experimental Lakes Area in Canada that revealed clear
evidence that the potent synthetic estrogen 17b-ethyny-
lestradiol (EE2) affects fish populations and their sup-
porting food web [7]. The population of the shortest-
lived fish species, the fathead minnow, collapsed after
two summers of EE2 additions. There is consequently
an urgent need in understanding the relevance of lab-
based experiments with endocrine disruptive chemicals
(EDCs) in context with ecological scenarios.
These reports and associated concerns regarding the
ubiquitous presences of EDCs in the environment have
sparked both scientific and political debates regarding
the need for strategies to assess and regulate chemicals
with endocrine disrupting (ED) properties to protect
human and environmental health. To address these
needs, a number of countries, multinational govern-
ments such as the European Union and inter-govern-
ment organizations (Organization for Economic
Cooperation and Development, OECD) have initiated or
amended programs to integrate EDCs into current stra-
tegies to assess chemical safety. These programs include
the Endocrine Disruptor Screening Program (EDSP) of
the US Environmental Protection Agency (US-EPA), the
Strategic Programs on Endocrine Disruptors (SPEED) of
the Japan Environment Agency, and the Joint Working
Group on Endocrine Disrupters Testing and Assessment
(EDTA) sponsored by the OECD.
While there is an increasing number of national and
international strategies and policies that aim to address
the phenomenon of endocrine disruption (ED) in con-
text with chemical risk assessment, no comparable
efforts to streamline and regulate exposure to EDCs in
the environment have been made, and to date no sepa-
rate water quality criteria or comparable environmental
standards exist. However, according to the European
Commission, the issue of endocrine disrupters will be
addressed specifically in the context of the Water Fra-
mework Directive (WFD) that identifies “Substances and
preparations, or the breakdown products of such, which
have been proved to possess carcinogenic or mutagenic
properties or properties which may affect steroidogenic,
thyroid, reproduction or other endocrine-related func-
tions in or via the aquatic environment” in its “Indica-
tive List of the Main Pollutants” of concern (European
Commission 2000) [8].
Current national and international EDC screening
programs and strategies
U.S. EPA - EDSP
One of the leading and first nationally, legally-binding
programs was the EDSP of the U.S. EPA, which
employs a battery of in vitro and in vivo screening
assays to assess the ED potential of a chemical. Specifi-
cally, the U.S. Congress included a provision in the
Food Quality Protection Act of 1996 adding section
408 to the Federal Food, Drug, and Cosmetic Act
(FFDCA). This section of the FFDCA requires EPA to
“... develop a screening program, using appropriate
validated test systems and other scientifically relevant
information, to determine whether certain substances
may have an effect in humans that is similar to an
effect produced by a naturally occurring estrogen, or
other such endocrine effect as the Administrator may
designate [[21] U.S.C. 346 (p)]”. Subsequent to passage
of the Act, EPA formed the Endocrine Disruptor
Screening and Testing Advisory Committee (EDSTAC)
[9], a committee of scientists and stakeholders that
was charged with the duty to provide EPA with recom-
mendations on how to implement its EDSP. Upon
recommendations from EDSTAC, the EDSP was
expanded using the administrator’s discretionary
authority to include the androgen and thyroid hor-
mone systems and wildlife effects as well as the origin-
ally mandated effects relating to estrogen. EPA
accepted the EDSTAC’s recommendations for a two-
tier screening program [9]. The focus of this two-tiered
program has been first to develop in vitro and in vivo
assays to identify and classify substances relative
to their potential interaction with endocrine systems
(Tier 1) and then to develop concentration-response
relationships in animal models (Tier 2).
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EDSP Tier 1 battery
The EDSP Tier 1 battery was designed to work as a whole
to allow detection of estrogen- and androgen-mediated
effects by various modes of action including receptor bind-
ing (agonist and antagonist) and transcriptional activation,
steroidogenesis, and hypothalamic-pituitary-gonadal
(HPG) feedback (Table 1). It is comprised of a combina-
tion of in vitro and in vivo assays that aim to complement
one another in the battery to enable the identification of
specific endocrine mechanisms of chemicals, and to relate
this to a biological response in a whole organism. In addi-
tion, rodent and amphibian in vivo assays were selected
for the proposed battery based on their capacity to detect
direct and indirect effects on thyroid function (hypothala-
mic-pituitary-thyroidal, HPT, feedback). Thus, the robust-
ness of the proposed battery is based on the strengths of
each individual assay and their complementary nature
within the battery to detect effects on the estrogen, andro-
gen or thyroid hormonal systems (Table 1).
EDSP Tier 2 battery
Once a chemical is identified as a potential EDC during
Tier 1 screening, EPA will require further testing in a
second tier. The purpose of this Tier 2 testing is to
identify further and characterize chemical-induced inter-
actions with estrogen, androgen, or thyroid hormonal
systems for risk assessment. To date, no definite deci-
sions have been made regarding the specific tests to be
included into the Tier 2 testing stage. It is anticipated,
however, that Tier 2 testing will focus on multi-genera-
tion testing with a broad range of taxa. Candidate assays
for Tier 2 testing include amphibian-, bird-, and mam-
malian-two-generation tests, as well as a fish- and inver-
tebrate(mysid)-life-cycle assay.
The US-EPA has started implementing its policies
regarding EDC testing. In 2009, it has sent out the
first test orders to industry requiring testing of 67
chemicals using the Tier 1 test battery. On November
17, 2010, the second list of chemicals for Tier 1
screening has been published. This list includes 134
chemicals and substances that have been listed as
priorities within EPA’s drinking water and pesticides
programs.
One of the greatest challenges of the EDSP is the cur-
rent lack of clear decision strategies and processes, or in
other words: what happens if a chemical is flagged as a
potential EDC during Tier 1 screening? While in theory
flagging a chemical during Tier 1 would trigger confir-
matory Tier 2 testing, it is unclear how and when this
will happen as candidate test guidelines for Tier 2 are
still under validation. Similarly, it is unclear what the
decision process for removing or limiting the use of che-
micals that tested positive will be. In conclusion, while
there has been some progress made regarding the regu-
lation of EDCs in the U.S.A. there is still a great deal of
uncertainty and lack of clear policies and available tools
that would allow moving a chemical smoothly through
the complete EDSP process.
Japan
Japan has been among the first nations to address the
issue of ED on a national level. In 1997 the Environ-
mental Agency of Japan initiated an “Exogenous Endo-
crine Disrupting Chemical Task Force” under
Tsuguyoshi Suzuki, which aimed to collect, review, and
organize scientific information available on the phenom-
enon of ED. In 1998, the Japan Environment Agency
Table 1 US-EPA’s tier 1 Battery, and modes of action detected
Direct Receptor Mediated Steroidogenesis
Ea Anti-Ea Aa Anti-Aa E-productiona A-productiona HPG-Axisb HPT-axisc
In Vitro
ER Bindinge X Xe
ERa TA X
AR Bindinge X X




Hershbergerh X X X
Pubertal maleh X X X X X
Pubertal femaleg X Xe X X X
Amphibian Metamorphosisi X
Fish short-term reproductionj X Xe X X X X X
aEstrogen and androgen; bhypothalamic-pituitary-gonadal axis; chypothalamic-pituitary-thyroidal axis; destrogen and androgenreceptor binding; eassays are
expected to detect anti-estrogens, but this was not established during the validation process since no estrogen receptor antagonists were tested; frecombinant
aromatase assay; gfemale rat; hmale rat; iamphibian metamorphosis assay; jreproduction test with male and female fish. Modified after http://www.epa.gov/endo/
pubs/assayvalidation/tier1battery.htm.
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has started the SPEED initiative. The agencies policies
set forth in SPEED included:
1. Promotion of field investigations into the present
state of environmental pollution and of adverse
effects on wildlife of endocrine disrupting chemicals;
2. Promotion of research and screening and testing
method development;
3. Promotion of environmental risk assessment, risk
management, and information dissemination; and
4. Strengthening of international networks.
Since then, Japan has been a strong supporter of
national research activities in the field of EDC. It has
supported a great deal of research in the field, and has
been actively involved in international initiatives such as
the Joint Working Group on EDTA sponsored by the
Organization for Economic Cooperation and Develop-
ment (OECD). Furthermore, the Ministry of Environ-
ment of Japan has worked together with the WHO/
UNEP/ILO International Programme on Chemical
Safety to host a joint workshop on “Endocrine Disrup-
tors: Research Needs and Future Directions” in Tokyo.
Based on the outcome of this workshop, a final report
has been published [10]. The report summarized the
current state-of-the-science in field of endocrine disrup-
tion, and identified key data gaps in that research area.
European Union
To date, no mandatory testing programs such as U.S.
EPA’s EDSP exist in Europe. However, the EU has
acknowledged the phenomenon of ED as a priority area,
and has developed short, medium and long-term strate-
gies to address this issue:
Short-term strategy
The short-term strategy of the EU as identified in the
European Commission’s Communication [11] was to
establish a priority list of candidate substances for
further evaluation of their ED properties. Prioritization
was to be conducted by an independent review of the
current state of knowledge regarding the endocrine dis-
rupting effects of and exposure to these chemicals in
humans and wildlife followed by consultation with sta-
keholders and the Commission’s Scientific Committees.
In 2007 the European Community published their third
progress report on the implementation of the “Commu-
nity Strategy for Endocrine Disrupters”, summarizing
the findings on the review of scientific information for
prioritizing of chemicals (European Commission 2007)
[12]. In total, 575 substances were investigated as to
their ED effects. In terms of prioritization, it was found
that, out of this number, 320 substances showed evi-
dence or potential evidence for ED effects, while in
total, 109 substances were not retained in the priority
list, either due to insufficient data on ED effects or
insufficient scientific evidence. One hundred and forty-
seven substances have been excluded from the evalua-
tion during the process as they were identified as double
entries, mixtures or of doubtful relevance.
An assessment of the legal status of the substances
with evidence or potential evidence of endocrine dis-
rupting effects showed, that the majority of them are
already subject to a ban or restriction or are addressed
under existing Community legislation, although for rea-
sons not necessarily related to endocrine disruption.
Furthermore, short-term strategies included communi-
cation to public and cooperation with other government
programs including Japan and the USA, and interna-
tional efforts including the WHO and OECD regarding
EDCs. The European Commission and the World
Health Organisation (WHO) have since co-operated,
through the International Programme for Chemical
Safety, on the maintenance of a global research inven-
tory, which is housed at the Commission’s Joint
Research Centre and on the compilation of a “Global
state-of-the-science of endocrine disruptors” report
(WHO 2002) [13]. The European Commission is actively
involved the efforts of the OECD to develop agreed test
methods for endocrine disrupters.
In 2000, the European Commission and United States
Environmental Protection Agency agreed to share infor-
mation on a regular basis on priority setting, screening
and testing as well as on research activities.
Medium-term strategy
Issues identified by the EU included the lack of under-
standing of the specific modes of action of potential
EDCs (most of the focus has been on estrogen (ER) and
androgen (AR) receptor agonists), the biological rele-
vance of many of the effects described at the biochem-
ical or molecular level, as well as the impact on humans
and wildlife. Also, there was the lack of appropriate test
methods and testing strategies to reliable assess the ED
potential of a substance, and of models that enable esti-
mating exposure to EDCs. Therefore, the European
Commission has made funding of research linked to ED
a priority for their fifth, sixth and seventh Framework
Programmes. Since the implementation of these frame-
work programs, the EU has funded a large number
(over 80) of research projects as part of their fifth, sixth
and seventh Framework Programmes including studies
in the area of human and wildlife health, development
of test methods, strategies, and risks assessment tools
(Table 2; http://ec.europa.eu/research/endocrine/).
Furthermore, the European Commission has worked
closely with its member states to coordinate the EU
input into the OECD EDTA to develop internationally
harmonized test methods and testing strategies for
EDCs. Many of these efforts are still ongoing.
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Table 2 Projects funded during the fourth through seventh Framework Programmes of the European Comission and
their area of research and completion status



















Aquatic wildlife (5) ACE; BEEP; BIOCET; COMPRENDO; FAMIZ 2000-
2005
X
Effects on bones (1) BONETOX 2003-
2006
X
Multi-organ effects of EDCs and risk assessment
(8)
COMPARE; DIOXIN RISK ASSESSMENT; EDEN; EURISKED;




Neurodevelopmental/endocrine effects (3) ANEMONE; PBDE-NTOX; SENSPESTI 2000-
2005
X
Phytoestrogens (2) PHYTO-PREVENT; PHYTOS 2001-
2004
X





Development of test methods and
technologies (4)









Risk assessment methods and tools (5) CEASAR; ESBIO; NOMIRACLE; NORMAN; SAFE FOODS 2004-
2009
X
Reproductive health outcomes (3) F&F; PIONEER; REPROTECT 2004-
2009
X
Neurodevelopmental effects and aging (2) DEVNERTOX; CRESCENDO 2003-
2011
X X
Review of state-of-the-art (1) HENVINET 2006-
2010
X
Development of in vitro technologies (1) BIOCOP 2005-
2010
X
Environmental causes of cancer (1) NEWGENERIS 2006-
2011
X
Food and feed chain (1) AQUAMAX 2006-
2010
X






Detection of contaminants (1) CONFIDENCE 2008-
2012
X
Improvement of risk assessment models,
methods, tools and management (11)
ARCRISK; CADASTER; COPHES; ENFIRO; ENRIECO; ENVIROGENO




Reproductive health outcomes (4) NECTAR; CONTAMED; DEER; REEF 2008-
2013
X
Metabolic disorders (1) OBELIX 2009-
2013
X
Others (2) CLEAR; ESCAPE 2008-
2013
X
Number in brackets: number of projects funded in this research area
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Long-term strategy
Long-term strategies of the EU are on the development
and adaptation of legislative instruments and policy
action that enable hazard identification, risk assessment
and risk management of EDCs. Specifically, current
initiatives such as Registration, Evaluation, Authorisation
and Restriction of Chemicals (REACH) and Environment
and Health Strategy (SCALE) shall serve as legislative fra-
meworks in support of the regulation of EDCs. Relevant
recent developments were the adoption of regulation
1907/2006 (REACH), formally adopted on 18 December
2006, the proposal for a directive setting environmental
quality standards for priority substances under the water
framework directive (2006) or the new pesticide regula-
tion 1107/2009 EEC [14,15] (to be applied in the Eur-
opean Union from 14 June 2011). Specifically, REACH
requires an authorization (and/or replacement by suitable
alternative substances or technologies) for substances
with endocrine disrupting properties, for which there is
scientific evidence of probable serious effects to human
health or the environment which give rise to an equiva-
lent level of concern as CMR-substances (carcinogens,
mutagens, toxic for reproduction - the two highest cate-
gories each), PBT-substances (persistent, bioaccumulative
and toxic) and vPvB substances (very persistent and very
bioaccumulative). For pesticides with similar properties
as these so-called REACH-SVCHs (substances of very
high concern according to REACH article 57) no authori-
zation shall be granted according to the new Regulation
(EC) No 1107/2009. Regarding wildlife, the new “endo-
crine cut-off criterion” states: “An active substance, safe-
ner or synergist shall only be approved if, on the basis of
the assessment of Community or internationally agreed
test guidelines, it is not considered to have endocrine dis-
rupting properties that may cause adverse effects on non-
target organisms unless the exposure of non-target
organisms to that active substance in a plant protection
product under realistic proposed conditions of use is
negligible” (EC 1107/2009, Annex II, 3.8.2). Thus, a para-
digm shift in regulatory decision making was introduced
for pesticides with endocrine properties: Instead of the
established risk-based approach, a hazard-based approach
is now required (i.e. only the proven presence or assumed
absence of endocrine disrupting properties shall be deci-
sive for a [non]authorization). However, specific scientific
criteria to support regulatory decision making on sub-
stances with endocrine disrupting properties both under
REACH and the new pesticide regulation are lacking
today and thus have to be developed and agreed upon (at
least in the EU) within the near future.
Oecd
Recognizing the global relevance of the issue of endo-
crine disruption, in addition to the US-EPA activities,
the OECD initiated a high-priority activity in 1998 to
revise existing, and to develop new test guidelines for
the screening and testing of potential endocrine disrupt-
ing chemicals. The OECD conceptual framework for
testing and assessment of potential endocrine disrupting
chemicals comprises five levels, each level corresponding
to a different level of biological complexity (OECD
2002) [16]. The framework was developed in consulta-
tion with member countries. Proposed testing schemes
were developed at critical workshops (i.e. the European
Workshop on the Impact of Endocrine Disrupters on
Human Health and Wildlife [Weybridge Workshop] and
the Joint SETAC (Society of Environmental Toxicology
and Chemistry) Europe/OECD/EC Expert Workshop on
Endocrine Modulators and Wildlife: Assessment and
Testing [EMWAT Workshop]), other national activities
such as US-EPA’s EDSTAC and research activities in
Japan, and industry initiatives. Since its initial establish-
ment, the framework has been revised to its current
form (Figure 1). It has to be noted that the conceptual
framework developed by the EDTA does not represent a
testing scheme but rather a tool box in which the var-
ious tests that can contribute information for the detec-
tion of the hazards of endocrine disruption are placed.
It is organized into five levels each corresponding to a
different level of biological complexity (for both toxico-
logical and ecotoxicological areas). The format of this
tool box is flexible, and it allows for assays and tests to
be added as deemed necessary based on new insights or
developments.
Drinking water, effluent and environmental
analysis and monitoring
EDCs in drinking water
As a part of the comprehensive review paper ‘Endocrine
Disruptors and Water Quality: A State-of-the-Art
Review’ by Burkhardt-Holm [17], the author investigated
the question whether drinking water could be a source
for the exposure of people to EDCs? The presence of
estrogenic chemicals in drinking water was reported
from several researchers from various countries (e.g.
[18]). Endocrine potentials of drinking water were
shown to be related to several substances that were
detected in Ground water. Recently, the joined BMBF
research project HoT [[19,20] and Wölz J, Grosshans K,
Streck G, Schulze T, Rastall A, Erdinger L, Brack W,
Fleig M, Kühlers D, Braunbeck T, Hollert H: Estrogen
receptor mediated activity in bankside groundwater,
with flood suspended particulate matter and floodplain
soil - An approach combining tracer substance, bioassay
and target analysis, submitted] funded by the German
Ministry for Education BMBF demonstrated that con-
taminated suspended particulate matter from the Rhine
river has the potential to influence drinking water
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recourses in floodplains and nearby areas used for
drinking water supply.
As shown by Pinto and Reali [21] and Wagner and
Oehlmann [22] mineral water bottled in polyethylene
terephthalate (PET) and water in glass bottles or even
tap water had some weak endocrine activity. For exam-
ple, additives such as bisphenol A that are used as plas-
ticizers in some packaging material were shown to leach
into the water. Seventy-eight percent of all samples
from PET bottles bought in Germany showed estrogenic
potentials with concentration equivalents of up to 75 ng
17b-estradiol/L [22]. In Italy, 10% of the investigated
samples showed estrogenic activity, with maximum con-
centration equivalents of 23 ng 17b-estradiol/L.
Although a endocrine effectiveness was shown in a cou-
ple of independent studies, a legislation specific for
endocrine disruptors is not in action in the European
Community to date [17]. However, due to increasing
public pressure and concerns, a few countries started
taking action regarding the regulation of EDCs asso-
ciated with food containers. For example, in September
2010, Canada became the first country to declare BPA
as a toxic substance and banned its use in certain
applications such as baby bottles [23]. In 2010, the Eur-
opean Union announced that it will follow Canada’s
example ban the use of bisphenol A in baby bottles
effective in 2011 http://www.reuters.com/article/2010/
11/25/us-eu-health-plastic-idUSTRE6AO3MS20101125.
Environmental sources and exposure to EDCs
A number of studies have been conducted to character-
ize the endocrine potential of municipal effluents
[24,25], surface water [26-28] and sediments
[26,27,29,30], and there has been increasing awareness
of the need for testing approaches targeting EDCs to be
included into current environmental assessments and
monitoring [31-36].
However, while there have been multiple efforts at the
national and international level to develop testing and
regulatory approaches EDCs in context with chemical
risk assessment, no such efforts have been undertaken
in context with environmental risk assessments, effluent
testing and the evaluation of drinking water safety and
agricultural practices. For example, programs such as
the European WFD (EC 2000/60/EG) or the US Clean
Water Act do not explicitly test for EDCs, and

















































Figure 1 OECD conceptual framework. OECD conceptual framework for the testing and assessment of endocrine disrupting chemicals in
accordance with the consensus reached during the 6th meeting of the EDTA Task Force. (Adapted from OECD 2002 [16]).
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considering the unique requirements and endpoints
required to assess the endocrine potential of a sample,
these programs are unlikely to appropriately address
exposure to these chemicals. This is of great concern
since recent studies revealed the relevance EDCs may
have in aquatic ecosystem. For example, Kidd et al. [7]
demonstrated declines in populations of certain fish spe-
cies after exposure to environmentally relevant concen-
trations of the synthetic estrogen ethinylestradiol in
whole lake experiments. Additionally, various studies
demonstrated the potential of sediment-bound EDCs to
cause adverse effects in aquatic wildlife using different
in vitro and in vivo assays [26,27,29,30,37-39].
Recent studies predicted that the objective of the
WFD to achieve good ecological/chemical status by
2015 is likely to fail in many European catchment areas
because of the continuing remobilization of sediment-
bound pollutants in heavily contaminated old sediments
[40-42]. As shown by several sediment toxicity studies
using mass balance calculation approaches and effect
directed analyses (for review see Hollert et al. [26] and
Brack et al., [32]), known endocrine active chemicals
such as bisphenol A and alkylphenols typically only
explain approximately 10% to 15% of the entire endo-
crine potential in aquatic systems but tend to contribute
at greater proportions to ED potential of particle-related
effects. Remobilization of sediments during flood events
is therefore of greatest relevance for the mass balance of
BPA and alkylphenols in rivers [43] (Figure 2). As a
consequence, in support of the assessments of risk and
fulfillment of regulatory needs there is need for EDA
driven studies identifying the large proportion of
unknown EDCs in river water and sediments.
Wastewater treatment plants
One of most important sources for EDCs are the efflu-
ent from sewage treatment plants. These facilities often
do not eliminate micropollutants completely, and thus,
are important point sources for these substances. In par-
ticular, concerns about EDCs in wastewater treatment
plants effluents stimulated the implementation of
advanced treatment steps for the elimination of trace
organic contaminants [44]. Estrogenically active com-
pounds like 17b-estradiol and 17a-ethinylestradiol, for
example, are removed by 99.9% and 78%, respectively,
with conventional wastewater treatment systems [45].
Elimination strongly depends on the treatment steps
(primary, secondary and tertiary), aerobic conditions,
temperatures, etc., and under certain conditions (e.g.
low temperature, no nitrification step) there are signifi-
cant concentrations of endocrine active chemicals such
as estrogens remaining in the treated effluent that is
released into the receiving water body [45,46]. Under
conditions such as occur in some U.K. rivers that have
very great sewage loads (often greater 25% up to greater
80%), remaining concentrations of estrogenic com-
pounds have been show to lead to adverse effects
including reproductive disturbances in wild fish popula-
tions [47]. Recently, in Europe, there is increasing pres-
sure to further develop advanced wastewater treatment
methods, such as ozonation and activated carbon treat-
ment for a broad application in municipal wastewater
treatment [34,48]. As a consequence, there are a number
of projects that have been initiated during recent years
to implement and evaluate the efficiency of these addi-
tional treatment steps regarding their potential to
remove endocrine active substances. Examples are the
“Strategy MICROPOLL"of the Federal Office for the
Environment in Switzerland and a series of projects sup-
ported by the MUNLV (Ministry for Climate Protection,
Environment, Agriculture, Nature Conservation and
Consumer Protection of the German State of North
Rhine-Westphalia). One of the key challenges arising in
context with these projects is the availability of reliable
and effective tools to assess the elimination efficiency of
the additional treatment steps. Given the complex nat-
ure of chemicals with endocrine-disrupting properties as
well as the likelihood of a large number of yet unknown
EDCs that are present in sewage effluent it would not
only be prohibitively expensive but also virtually impos-
sible to analytically identify all of these chemicals due to
detection limits in the available analytical methodolo-
gies. Therefore, there is an increasing trend towards the
use of bio-analytical techniques that allow detecting spe-
cific groups of chemicals based on their common prop-
erties to interact with specific biological processes/
pathways [31]. Accordingly, such bio-analytical tools are
increasingly used in the above-described projects for
identifying the most efficient elimination method. Preli-
minary biotest data obtained by means of in vitro tests
such as the ER-CALUX, and the L-YES/YAS revealed
the effective removal of estrogenic activity by ozonation
[49-51]. In contrast, ozonation resulted only in a minor
attenuation of the toxic effects as detected after expo-
sure of rainbow trout (Oncorhynchus mykiss) and steroi-
dogenic active cells to effluent when using the fish early
life stage toxicity test [44] and the H295R-Assay [49-51],
respectively. As shown by Stalter et al. [44] the combi-
nation of ozonation and sand filtration is suitable to
prevent from adverse ecotoxicological effects of ozona-
tion. Additionally, in the Lausanne pilot study of the
strategy MICROPOLL project a stronger amelioration of
toxic effects as well as a strong reduction in the induc-
tion of plasma vitellogenin concentrations in male fish
was observed after advanced wastewater treatment [52].
This is in accordance to the study of Nakada et al. [53]
that demonstrated that a combination of ozonation,
sand filtration and activated sludge treatment gives the
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best removal result for EDCs. To remove EDCs in the
drinking water treatment process, granular activated car-
bon has been identified as the preferable method to be
used (US-EPA 2001; [17,54]).
Testing and screening approaches and tool boxes
Recently, the Global Water Research Coalition
(GWRC) conducted an inter-lab comparison study in
order to evaluate the performance of five in vitro
bioassays, including yeast estrogen screen (YES), ER-
CALUX, MELN, T47D-KBluc and E-Screen assays to
assess estrogenic activity in a variety of water matrices
http://www.edctoolbox.info, [55]. The study concluded
that some bioassay techniques are now sufficiently
advanced that they can be used either as a cost-effec-
tive first-pass detection system or in combination with
standard analytical methods to measure estrogenic pol-
lutants in environmental waters. However, standardiza-
tion of bioassay data analysis was identified as a crucial
step forward towards accurate bioassay-derived estro-
genicity measurements.
Recently, Kase et al. [56] published an extensive litera-
ture review survey aiming to give an overview and an
evaluation on available and validated biological test sys-
tems for the detection of endocrine disruptive and
reproductive effects in aquatic systems for monitoring
purposes. Based on the review and an international
workshop organized by the Swiss Centre for Applied
Ecotoxicology of Eawag/EPFL (Ecotox Centre, Dueben-
dorf, Switzerland) a recommendation for a modular eco-
toxicological test platform was given. The study focused
on test methods for sex hormonal active substances but
also considered alternative MOAs such as effects on
hormone production. On the basis of the literature
search and ongoing international validation efforts by
the OECD for methods to detect endocrine disruptive
effects, 15 biological test methods (five in vivo and ten
in vitro) were selected including eight OECD methods
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Figure 2 Concentrations of suspected endocrine active substances and suspended particulate matter. Concentrations of suspected
endocrine active substances in water samples and suspended particulate matter during a flood event (River Neckar, Heidelberg, in November/
December 1998). The discharge of the flood event is given without dimension and should elucidate that during the maximum of a given flood
event greatest concentrations of alkylphenols can be observed (data Holtey Weber, redrawn according to Hollert 2001 [43]).
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and three out of five in vitro methods mentioned in the
Global Water Research Coalition (GWRC) report. Kase
et al. [56] further recommend a testing strategy based
on their review to assess the ecotoxicological relevance
of EDCs (Figure 3). The applicability for testing and
screening of environmental samples regarding their
endocrine disrupting properties is currently tested in a
joint project coordinated by the Ecotox Centre. http://
www.oekotoxzentrum.ch/projekte/micropolleffektbewer-
tung/index
Current issues and uncertainties
There has been a great deal of progress over the past
decade to address scientific uncertainties and regulatory
needs concerning EDCs. A large number of national and
international programs have been initiated, and efforts
have been made to harmonize testing methods in con-
text with chemical risks assessment of EDCs. However,
there are still a number of remaining concerns and
uncertainties.
Alternatives to animal testing
One of the key issues remaining in context with the
globally increasing number of testing programs to assess
the potential of chemicals to disrupt endocrine functions
is the reliance on a large number of in vivo tests using
live animals. With increasing testing demands and
requirements the number of rats, mice, fish and frogs
needed to fulfill these will grow proportionally. For
example, subjecting a single chemical to the complete
Tier 1 testing battery of US-EPA’s EDSP would require
approximately 130 rats, 30 tadpoles/froglets and 60 fish.
Considering the vast amount of chemicals ultimatively
to be tested (approximately 80,000) this would result in
the sacrifice of millions of animals. This represents both
an ethical and economical problem. To reduce the num-
ber of test animals, therefore, programs such as the
EDSP have made increasingly attempts to include
in vitro methodologies that are based on stable cells
lines or sub-cellular compartments and modeling
approaches (e.g. QSAR) in their testing scheme where
possible. Similar trends are observed in other parts of
the world such as Europe, and international organization
such as the OECD are promoting the use of alternative
testing methods through groups such as the Non Ani-
mal Testing Validation and Management Group.
While these efforts are promising, there is still a great























Figure 3 Proposed modular test platform. To identify and assess the endocrine potential of environmental samples using a combination of in
vivo and in vivo bioassays. Dotted boxes refer to optional tests (redrawn and adapted from Kase et al. [56]).
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a replacement of in vivo assays. Specifically, there is a
lack of understanding of the relevance of results
obtained by means of in vitro assays to whole organisms.
In vitro systems often represent highly simplified and/or
artificial (e.g. yeast cells transfected with a human recep-
tor) systems that lack the complexity of an organism
with its feedback loops, cross-talk between different bio-
logical pathways, metabolism, etc. There have been a
few studies in the past that compared in vitro with in
vivo data, and which have produced ambiguous results
(e.g. [57,58]). In general, however, our understanding of
the biological pathways currently used in vitro assays are
“equipped” with is rather limited, and there is need for
additional studies specifically designed to address these
uncertainties. Similarly, many in vitro but also some in
vivo assays make decisions based on effects that are
measured at the sub-organismal (molecular, sub-cellular
or cellular) level. What is often lacking, though, is the
ability to link these endpoints with biological relevant
responses [59]. Thus, one of the key future challenges is
to align the primary mechanistic data obtained by
means of genomic or other sub-organismal studies with
outcomes of demographic relevance such as survival and
reproduction. In fact, recent efforts are underway to
align the mechanistic data obtained by means of geno-
mic or other sub-organismal studies with apical end-
points that are required in risk assessment, and which
have been termed adverse outcome pathways (AOPs;
[60]). AOPs present a promising concept that aims to
identify critical initiating molecular events that are spe-
cific to certain vital pathways. For example, vitellogenin
(VTG; egg yolk protein) production by females is a pre-
requisite for successful egg production in egg-laying ver-
tebrates, and inhibition of VTG synthesis has been suc-
cessfully used as a predictor of decreased fecundity [60].
Harmonization of testing methods and strategies
Another main issue is the lack of streamlined and glob-
ally harmonized and accepted methodologies and proce-
dures to assess ED properties of chemicals and
environmental samples. In the chemical risk assessment
scene the need for such harmonization efforts is increas-
ingly recognized. As discussed above, this resulted in a
number of efforts at the national and international level
to develop and harmonize testing approaches and regu-
late EDCs. It should be recognized, however, that many
of these efforts are still in their infancy, and that there is
need for internationally recognized and harmonized
science-based decision criteria that clearly enable the
identification of EDCs and subsequent needs for regulat-
ing these substances. No such efforts have been under-
taken in context with environmental risk assessment
approaches, effluent testing and the evaluation of drink-
ing water safety and agricultural practices. Furthermore,
current environmental monitoring programs such as the
European WFD primarily rely on chemical analytical
data and do not consider effect-based ecotoxicological
assessment. However, combined approaches using bioa-
nalytical tools and chemical measurements have been
shown to be powerful and promising tools for the iden-
tification of novel or unexpected toxicants causing
adverse effects in biological systems. For example, nat-
ural estrogenic steroids together with the synthetic con-
traceptive pill component ethinylestradiol - originating
primarily from wastewater treatment plants - have been
identified by EDA as major estrogens in water samples
and fish bile [32,61,62]. Based on these findings, these
compounds moved into the focus of monitoring, risk
assessment and technological improvements for waste-
water treatment plants [32]. Ethinylestradiol is now
listed as a candidate for European priority pollutants.
This demonstrates the potential and relevance of con-
cepts such as EDA or TIE (toxicity identification and
evaluation) in support of current environmental moni-
toring strategies [31].
Invertebrates
As outlined above, recent reports have shown that a
number of xenobiotics in the environment are capable
of interfering with the normal endocrine function in a
variety of animals. The overwhelming majority of the
studies on the effects of hormone-mimetic industrial
chemicals were focused on findings in vertebrates [63].
Although approximately 95% of known species in the
animal kingdom are invertebrates, studies on the effects
of EDCs on invertebrates are still scarce. According to
the results of the SETAC workshop on Endocrine Dis-
ruption in Invertebrates, only 10% of these invertebrate
studies were conducted with terrestrial invertebrates
[64]. As stated by Oehlmann-Schulte and Oehlmann
[63] the limited number of examples for EDCs in inver-
tebrates is partially due to the fact that their hormonal
systems are rather poorly understood in comparison
with vertebrates. Recently, Lemons and coworkers [65]
showed that both bisphenol A and vinclozolin disrupt
the endocrine function of important representatives of
soil edaphic invertebrates. In the study, enhanced mor-
tality turned out to be the effect of incomplete ecdysis
related to increased ecdysteroids titres. Lemons and
coworkers [65] concluded therefore, that ‘hyperecdyson-
ism’ might be a promising endpoint to detect and assess
EDCs in arthropods inhabiting the terrestrial environ-
ment. Despite these few successful examples of potential
methodologies to characterize and assess ED in inverte-
brates, there is still a great deal of uncertainty and lack
of appropriate methods regarding the assessment of
EDC effects in this group of organisms. In order to be
able to establish relevant environmental monitoring and
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assessment programs for EDCs, however, it would be
essential to include ED effects on invertebrates because
they represent a critical aspect in the food-web of prac-
tically all ecosystems.
Conclusions
The past two decades have witnessed a significant
increase in efforts to improve and harmonize strategies
and approaches to assess the risks of EDCs to humans
and the environment. Regulatory structures have been
or are currently established in the USA, Japan and Eur-
ope, and the first mandatory testing program, the EDSP,
has been implemented by the US-EPA. Through
OECD’s joint EDTA working group a global platform
for the harmonization and general acceptance of tests to
assess the potential of chemicals to interact with the
endocrine system has been generated. The increasing
requirements for testing and screening, however, have
create new issues, and there are great concerns regard-
ing the dramatic increase in use of live test organisms
and huge costs associated with extensive testing. In
response to these concerns, there is a growing demand
for alternative testing strategies including priority set-
ting, tiered screening, and the use of in silico systems
and in vitro assays. However, many of these alternative
approaches still require validation and/or calibration
with regard to their predictive power and relevance for
living organisms. Additional efforts to improve current
risk assessment strategies for EDCs include the use of
advance omic technologies to aid in identifying critical
pathways and molecular endpoints that can be used to
define AOPs that enable prediction of biological relevant
effects. While there have been a great number of efforts
in support of improving and streamlining chemical risk
assessment for EDCs, similar efforts in context with
environmental screening and risk assessments are still in
their infancy. Moreover, programs such as the European
WFD or the US Clean Water Act do not explicitly test
for EDCs, and considering the unique requirements and
endpoints required to assess the endocrine potential of a
sample, these programs are unlikely to appropriately
address exposure to these chemicals. Thus, there is a
strong need for similar validation and harmonization
programs as they currently exist in the field of chemical
risk assessment. In fact, it may be beneficial to draw on
the extensive experiences and “lessons learned” from
current chemical screening and assessment programs
such as the EDSP. Finally, current research and regula-
tory strategies tend to focus on human and vertebrate
health. Especially form an environmental protection per-
spective, however, the group of invertebrates represents
an ecologically very important factor as they form the
basis for most food-webs. Thus, in favor of a holistic
approach and the improvement of current environmental
risk assessment strategies, there is urgent need for estab-
lishing tools and approaches that enable the characteriza-
tion and evaluation of EDC effects in invertebrates.
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